Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,881 | 123 | 99.1% |
| Education | $17.41 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $596.93 | 43 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $338.37 | 17 | $0 (2022) |
| Astellas Pharma US Inc | $194.24 | 16 | $0 (2023) |
| Novo Nordisk Inc | $165.19 | 12 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $142.05 | 11 | $0 (2022) |
| GlaxoSmithKline, LLC. | $117.97 | 7 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $55.51 | 3 | $0 (2022) |
| Medtronic, Inc. | $52.26 | 1 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $50.80 | 4 | $0 (2018) |
| Merck Sharp & Dohme LLC | $31.02 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $147.31 | 9 | GlaxoSmithKline, LLC. ($53.11) |
| 2022 | $238.06 | 16 | Sunovion Pharmaceuticals Inc. ($69.54) |
| 2021 | $94.54 | 4 | Medtronic, Inc. ($52.26) |
| 2020 | $110.50 | 8 | Amgen Inc. ($51.52) |
| 2019 | $278.61 | 13 | Novartis Pharmaceuticals Corporation ($147.23) |
| 2018 | $602.78 | 48 | Amgen Inc. ($242.91) |
| 2017 | $426.90 | 28 | Amgen Inc. ($217.82) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Central Nervous System | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: VACCINES | ||||||
| 06/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Biological | ||||||
| 06/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: RESPIRATORY | ||||||
| 04/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: RESPIRATORY | ||||||
| 04/20/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Urology | ||||||
| 03/23/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $16.78 | General |
| 03/14/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: UROLOGY | ||||||
| 03/01/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
| 12/05/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: UROLOGY | ||||||
| 11/29/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Urology | ||||||
| 11/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardio-renal | ||||||
| 10/11/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: UROLOGY | ||||||
| 08/31/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: VACCINE | ||||||
| 08/17/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: UROLOGY | ||||||
| 08/16/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardio-renal | ||||||
| 07/18/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: UROLOGY | ||||||
| 06/30/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Cardio-renal | ||||||
| 06/28/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: UROLOGY | ||||||
| 05/31/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: UROLOGY | ||||||
| 05/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,570 | 3,107 | $330,058 | $155,945 |
| 2022 | 43 | 3,995 | 7,392 | $656,112 | $331,463 |
| 2021 | 64 | 7,375 | 12,407 | $898,365 | $381,171 |
| 2020 | 60 | 7,144 | 12,298 | $858,172 | $330,626 |
All Medicare Procedures & Services
188 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 430 | 827 | $123,951 | $59,327 | 47.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 266 | 266 | $72,352 | $31,451 | 43.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 123 | 705 | $54,285 | $28,168 | 51.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 292 | 449 | $45,798 | $21,636 | 47.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 19 | $5,890 | $3,515 | 59.7% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 23 | 24 | $3,240 | $2,253 | 69.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 41 | 43 | $5,504 | $2,162 | 39.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 62 | $3,286 | $2,093 | 63.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $2,640 | $1,799 | 68.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 23 | 24 | $1,464 | $917.52 | 62.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 19 | $931.00 | $508.98 | 54.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 26 | 101 | $1,717 | $385.04 | 22.4% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 72 | 77 | $1,232 | $321.86 | 26.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 31 | $1,240 | $278.64 | 22.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 75 | 89 | $1,424 | $276.79 | 19.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 12 | 15 | $915.00 | $262.90 | 28.7% |
| 85610 | Blood test, clotting time | Office | 2023 | 13 | 59 | $1,062 | $247.80 | 23.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $1,140 | $177.65 | 15.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 142 | $568.00 | $85.63 | 15.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 33 | $429.00 | $72.60 | 16.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 14 | 90 | $990.00 | $6.82 | 0.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 485 | 1,144 | $171,302 | $96,324 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 468 | 1,137 | $115,836 | $66,100 | 57.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 417 | 417 | $113,424 | $50,445 | 44.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 154 | 1,002 | $77,154 | $42,731 | 55.4% |
About Dr. Tim Paden, M.D
Dr. Tim Paden, M.D is a Family Medicine healthcare provider based in Mountain Home, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992761555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tim Paden, M.D has received a total of $1,899 in payments from pharmaceutical and medical device companies, with $147.31 received in 2023. These payments were reported across 126 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,881).
As a Medicare-enrolled provider, Paden has provided services to 20,084 Medicare beneficiaries, totaling 35,204 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 188 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mountain Home, AR
- Active Since 04/24/2006
- Last Updated 01/24/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992761555
Products in Payments
- Prolia (Biological) $376.15
- ENTRESTO (Drug) $316.01
- MYRBETRIQ (Drug) $106.58
- Aimovig (Biological) $105.06
- GEMTESA (Drug) $82.38
- Myrbetriq (Drug) $74.55
- Victoza (Drug) $68.10
- Repatha (Biological) $62.44
- Ozempic (Drug) $56.17
- Kerendia (Drug) $55.51
- Minimed 770G System (Device) $52.26
- TRELEGY ELLIPTA (Drug) $51.51
- TOUJEO (Drug) $50.80
- EVENITY (Biological) $46.39
- LONHALA MAGNAIR (Drug) $31.48
- UTIBRON (Drug) $29.36
- FLULAVAL (Biological) $24.80
- LYRICA (Drug) $24.01
- GVOKE HYPOPEN (Drug) $18.88
- Austedo XR (Drug) $18.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mountain Home
Dr. Edward White, M.d, M.D
Family Medicine — Payments: $5,253
Dr. Michael Hodges, M.d, M.D
Family Medicine — Payments: $5,244
Sharon Pritchard, Md, MD
Family Medicine — Payments: $4,047
Dr. Kevin Adkins, M.d, M.D
Family Medicine — Payments: $3,621
Dr. Ronald Bruton, Md, MD
Family Medicine — Payments: $2,856
Dr. Michael Hagaman, Md, MD
Family Medicine — Payments: $2,528